• Secondary end points included overall survival (OS) and overall response rate (ORR) per IRC.

    次要终点包括IRC评估的总生存期(OS)和总缓解率(ORR)。

    youdao

  • The primary end point was overall response rate (ORR) per investigator assessment (RECIST 1.1).

    主要研究终点为总缓解率(ORR),采用评价标准为RECIST 1.1。

    youdao

  • Conclusions: in patients with advanced larynx and hypopharynx carcinomas, TPF induction chemotherapy was superior to the PF regimen in terms of overall response rate.

    结论:进展期喉癌和咽喉癌患者中,TPF诱导化疗的总体反应率高于PF化疗方案。

    youdao

  • Results: of 33 evaluated patients, a 70% overall response rate (complete response plus complete response unconfirmed, 45%) and a median progression-free survival (PFS) of 16.5 months were achieved.

    结果:在33个被评估的病人中,总的反应率为70%(完全反应率加未确定的完全反应率,45%),中位无进展生存期为16.5个月。

    youdao

  • Results: of 33 evaluated patients, a 70% overall response rate (complete response plus complete response unconfirmed, 45%) and a median progression-free survival (PFS) of 16.5 months were achieved.

    结果:在33个被评估的病人中,总的反应率为70%(完全反应率加未确定的完全反应率,45%),中位无进展生存期为16.5个月。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定